UMediC Group Berhad Total Liabilities

Latest as of October 2025: RM11.72 Million MYR ≈ $2.94 Million USD

UMediC Group Berhad total liabilities. Based on the latest financial reports, UMediC Group Berhad (0256) has total liabilities worth RM11.72 Million MYR (≈ $2.94 Million USD) as of October 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of UMediC Group Berhad to evaluate the company's liquid asset resilience ratio.

Total Liabilities of UMediC Group Berhad (2020–2025)

Total liabilities of UMediC Group Berhad from 2020 to 2025. This chart illustrates how UMediC Group Berhad's total liabilities have evolved over time, based on quarterly financial data.

UMediC Group Berhad Competitors by Total Liabilities

The table below lists competitors of UMediC Group Berhad ranked by their total liabilities.

Company Country Total Liabilities
Demire Deutsche Mittelstand Real Estate AG
F:DMRE
Germany €689.01 Million
Camellia Metal Co Ltd
TWO:2064
Taiwan NT$1.52 Billion
Yung Zip Chemical Ind Co Ltd
TWO:4102
Taiwan NT$261.24 Million
Aetherium Acquisition Corp
NASDAQ:GMFI
USA $10.13 Million
Transtema Group AB
ST:TRANS
Sweden Skr1.00 Billion
Cheetah Mobile Inc
NYSE:CMCM
USA $2.84 Billion
Lysaght Galvanized Steel Bhd
KLSE:9199
Malaysia RM8.21 Million
Deep Value Driller AS
OL:DVD
Norway Nkr166.61 Million

Liability Composition Analysis (2020–2025)

This chart breaks down UMediC Group Berhad's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 0256 current and non-current assets.

Liquidity & Leverage Metrics

UMediC Group Berhad Total Liabilities Ratios Explained

UMediC Group Berhad total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 7.22 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.14 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.12 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how UMediC Group Berhad's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for UMediC Group Berhad (2020–2025)

The table below shows the annual total liabilities of UMediC Group Berhad from 2020 to 2025.

Year Total Liabilities Change
2025-07-31 RM9.87 Million
≈ $2.48 Million
-0.70%
2024-07-31 RM9.93 Million
≈ $2.49 Million
+1.21%
2023-07-31 RM9.82 Million
≈ $2.46 Million
-39.46%
2022-07-31 RM16.21 Million
≈ $4.07 Million
-52.58%
2021-07-31 RM34.19 Million
≈ $8.58 Million
+47.06%
2020-07-31 RM23.25 Million
≈ $5.84 Million
--

About UMediC Group Berhad

KLSE:0256 Malaysia Medical Devices
Market Cap
$24.88 Million
RM99.09 Million MYR
Market Cap Rank
#24261 Global
#625 in Malaysia
Share Price
RM0.27
Change (1 day)
-3.64%
52-Week Range
RM0.26 - RM0.44
All Time High
RM0.89
About

UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales s… Read more